Radioembolization with 90Y-labeled microspheres: Post-therapeutic therapy validation with Bremsstrahlung-SPECT;Radioembolisation mit 90 Y-markierten Mikrosphären: Posttherapeutische Therapievalidierung mit Bremsstrahlungs-SPECT

Zeitschrift fur Medizinische Physik

Volumn 21, Issue 4, 2011, Pages 274-280

  Großer, Oliver S ^a,b   Nultsch, Madeleine ^a   Laatz, Kathleen ^a   Ulrich, Gerd ^a   Seidensticker, Ricarda ^a   Pethe, Annette ^a   Dudeck, Oliver ^a   Pech, Maciej ^a   Knoop, Bernd O ^b   Ricke, Jens ^a   Amthauer, Holger ^a   Geworski, Lilli ^b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

90Y Microspheres; Bremsstrahlung Imaging; Selective Internal Radiotherapy; Therapy Validation

Indexed keywords

MICROSPHERE; YTTRIUM 90;

ARTICLE; BREMS RADIATION; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; GAMMA RADIATION; HUMAN; LIVER CANCER; RADIOISOTOPE DECAY; SELECTIVE INTERNAL RADIOTHERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BODY BURDEN; DOSE-RESPONSE RELATIONSHIP, RADIATION; EMBOLIZATION, THERAPEUTIC; HUMANS; LIVER; LIVER NEOPLASMS; MICROSPHERES; PALLIATIVE CARE; PHANTOMS, IMAGING; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 83355173991     PISSN: 09393889     EISSN: 18764436     Source Type: Journal    
DOI: 10.1016/j.zemedi.2011.05.002     Document Type: Article

References (41)

1. Kwekkeboom D., Krenning E.P., de Jong M. Peptide Receptor Imaging and Therapy. J Nucl Med. 2000, 41:1704-1713.
2. Kwekkeboom D.J., Mueller-Brand J., Paganelli G., et al. Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs. J Nucl Med. 2005, 46:S62-S66.
3. Morschhauser F., Dreyling M., Rohatiner A., Hagemeister F., Bischof Delaloye A. Rationale for Consolidation to Improve Progression-Free Survival in Patients with Non-Hodgkin's Lymphoma: A Review of the Evidence. Oncologist. 2009, 14:S17-29.
4. Buchegger F., Press O.W., Delaloye A.B., Ketterer N. Radiolabeled and Native Antibodies and the Prospect of Cure of Follicular Lymphoma. Oncologist. 2008, 13:657-667.
5. Pagel J.M. Radioimmunotherapeutic approaches for leukemia: the past, present and future. Cytotherapy. 2008, 10:13-20.
6. Kletting P., Reske S.N., Glatting G. Dependence of the anti-CD66 antibody biodistribution on the dissociation constant: A simulation study. Z Med Phys. 2011 Apr 27, [Epub ahead of print].
7. Helmberger T., Hoffmann R.T., Jakobs T., Leibecke T., Lubienski A., Reiser M. Liver Tumor Ablation. Radiologe. 2005, 45:55-62.
8. Welsh J.S., Kennedy A.S., Thomadsen B. Selective Internal Radiation Therapy (SIRT) for Liver Metastases Secondary to Colorectal Adenocarcinoma. Int J Radiat Oncol Biol Phys. 2006, 66:S62-73.
9. Kennedy A.S., McNeillie P., Dezarn W.A., Nutting C., Sangro B., Wertman D., et al. Treatment Parameters and Outcome in 680 Treatments of Internal Radiation with Resin 90Y-Microspheres for Unresectable Hepatic Tumors. Int J Radiat Oncol Biol Phys. 2009, 74:1494-1500.
10. Stribley K.V., Gray B.N., Chmiel R.L., Heggie J.C., Bennett R.C. Internal Radiotherapy for Hepatic Metastases I: The Homogeneity of Hepatic Arterial Blood Flow. J Surg Res. 1983, 34:17-24.
11. Stribley K.V., Gray B.N., Chmiel R.L., Heggie J.C., Bennett R.C. Internal Radiotherapy for Hepatic Metastases II: The Blood Supply to Hepatic Metastases. J Surg Res. Jan 1983, 34:25-32.
12. Muller J.H., Rossier P.H. Treatment of Cancer of the Lungs by Artificial Radioactivity. Experientia 1947, 3:75.
13. Murthy R., Nunez R., Szklaruk J., Erwin W., Madoff D.C., Gupta S., et al. Yttrium-90 Microsphere Therapy for Hepatic Malignancy: Devices, Indications, Technical Considerations, and Potential Complications. Radiographics. 2005, 25:S41-55.
14. Campbell A.M., Bailey I.H., Burton M.A. Tumour Dosimetry in Human Liver Following Hepatic Yttrium-90 Microsphere Therapy. Phys Med Biol. 2001, 46:487-498.
15. Archer S.G., Gray B.N. Vascularization of Small Liver Metastases. Br J Surg. Jun 1989, 76:545-548.
16. Breedis C., Young G. The Blood Supply of Neoplasms in the Liver. Am J Pathol. 1954, 30:969-977.
17. Ridge J.A., Bading J.R., Gelbard A.S., Benua R.S., Daly J.M. Perfusion of Colorectal Hepatic Metastases. Relative Distribution of Flow from the Hepatic Artery and Portal Vein. Cancer. 1987, 59:1547-1553.
18. Kennedy A.S., Dezarn W.A., McNeillie P., Coldwell D., Nutting C., Carter D., et al. Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients. Am J Clin Oncol. 2008, 31:271-279.
19. Denecke T., Ruhl R., Hildebrandt B., Stelter L., Grieser C., Stiepani H., et al. Planning Transarterial Radioembolization of Colorectal Liver Metastases with Yttrium 90 Microspheres: Evaluation of a Sequential Diagnostic Approach Using Radiologic and Nuclear Medicine Imaging Techniques. Eur Radiol. 2008, 18:892-902.
20. Hamami M.E., Poeppel T.D., Muller S., Heusner T., Bockisch A., Hilgard P., et al. SPECT/CT with 99mTc-MAA in Radioembolization with 90Y Microspheres in Patients with Hepatocellular Cancer. J Nucl Med. 2009, 50:688-692.
21. Ahmadzadehfar H., Sabet A., Biermann K., Muckle M., Brockmann H., Kuhl C., et al. The significance of 99mTc-MAA SPECT/CT Liver Perfusion Imaging in Treatment Planning for 90Y-Microsphere Selective Internal Radiation Treatment. J Nucl Med. 2010, 51:1206-1212.
22. Minarik D., Sjögreen-Gleisner K., Ljungberg M. Evaluation of Quantitative 90Y SPECT Based on Experimental Phantom Studies. Phys Med Biol. 2008, 53:5689-5703.
23. Sarfaraz M., Kennedy A.S., Lodge M.A., Li X.A., Wu X., Yu C.X. Radiation Absorbed Dose Distribution in a Patient Treated with Yttrium-90 Microspheres for Hepatocellular Carcinoma. Med Phys. 2004, 31:2449-2453.
24. Ito S., Kurosawa H., Kasahara H., Teraoka S., Ariga E., Deji S., et al. Y-90 Bremsstrahlung Emission Tomography Using Gamma Cameras. Ann Nucl Med. 2009, 23:257-267.
25. Fabbri C., Sarti G., Cremonesi M., Ferrari M., Di Dia A., Agostini M., et al. Quantitative analysis of 90Y Bremsstrahlung SPECT-CT Images for Application to 3D Patient-Specific Dosimetry. Cancer Biother Radiopharm. 2009, 24:145-154.
26. Cross W.G., Ing H., Freedman N. A Short Atlas of Beta-Ray Spectra. Phys Med Biol. 1983, 28:1251-1260.
27. Gulec S.A., Mesoloras G., Dezarn W.A., McNeillie P., Kennedy A.S. Safety and Efficacy of Y-90 Microsphere Treatment in Patients with Primary and Metastatic Liver Cancer: The Tumor Selectivity of the Treatment as a Function of Tumor to Liver Flow Ratio. J Transl Med. 2007, 5:15-23.
28. Knoll G.F. Radiation Detection and Measurement 1989, Whiley, New York. 2nd ed.
29. Hudson H.M., Larkin R.S. Accelerated Image Reconstruction Using Ordered Subsets of Projection Data. IEEE Trans Med Imaging. 1994, 13:601-609.
30. Chang L.T. A Method for Attenuation Correction in Radionuclide Computed Tomography. IEEE Trans Nucl Sci. 1978, 25:638-643.
31. Zimmermann L., Dudeck O., Schmitt J., Ricke J., Roessner A., Malfertheiner P., et al. Duodenal Ulcer due to Yttrium Microspheres Used for Selective Internal Radiation Therapy of Hepatocellular Cancer. Gastrointest Endosc. 2009, 69:977-978.
32. Jakobs T.F., Hoffmann R.-T., Fischer T., Fischer T., Stemmler H.J., Tatsch K., et al. Radioembolization in Patients with Hepatic Metastases from Breast Cancer. JVIR. 2008, 19:683-690.
33. Neff R., Abdel-Misih R., Khatri J., Dignazio M., Garcia M., Petrelli N., et al. The Toxicity of Liver Directed Yttrium-90 Microspheres in Primary and Metastatic Liver Tumors. Cancer Invest. 2008, 26:173-177.
34. Clarke L.P., Cullom S.J., Shaw R., Reece C., Penney B.C., King M.A., et al. Bremsstrahlung Imaging Using the Gamma Camera: Factors Affecting Attenuation. J Nucl Med. Jan 1992, 33:161-166.
35. Cipriani C., Atzei G., Argiro G., Boemi S., Shukla S., Rossi G., et al. Gamma Camera Imaging of Osseous Metastatic Lesions by Strontium-89 Bremsstrahlung. Eur J Nucl Med. Nov 1997, 24:1356-1361.
36. Oda H., Hara H., Ueda O., Kawamata H., Sakai H., Katou Y., et al. Underlying Examination in the Imaging of 89Sr Bremsstrahlung Radiation. Nippon Hoshasen Gijutsu Gakkai Zasshi. 2010, 66:764-773.
37. Siegel J.A., Zeiger L.S., Order S.E., Wallner P.E. Quantitative Bremsstrahlung Single Photon Emission Computed Tomographic Imaging: Use for Volume, Activity, and Absorbed Dose Calculations. Int J Radiat Oncol Biol Phys. 1995, 31:953-958.
38. Mansberg R., Sorensen N., Mansberg V., Van der Wall H. Yttrium 90 Bremsstrahlung SPECT/CT Scan Demonstrating Areas of Tracer/Tumour Uptake. Eur J Nucl Med Mol Imaging. 2007, 34:1887.
39. Geworski L., Knoop B.O., de Cabrejas M.L., Knapp W.H., Munz D.L. Recovery Correction for Quantitation in Emission Tomography: A Feasibility Study. Eur J Nucl Med Mol Imaging. 2000, 27:161-169.
40. Lambert B., Mertens J., Sturm E.J., Stienaers S., Defreyne L., D'Asseler Y. 99mTc-Labelled Macroaggregated Albumin (MAA) Scintigraphy for Planning Treatment with 90Y Microspheres. Eur J Nucl Med Mol Imaging. 2010, 37:2328-2333.
41. Murthy R., Xiong H., Nunez R., Cohen A.C., Barron B., Szklaruk J., et al. Yttrium 90 Resin Microspheres for the Treatment of Unresectable Colorectal Hepatic Metastases After Failure of Multiple Chemotherapy Regimens: Preliminary Results. J Vasc Interv Radiol. 2005, 16:937-945.